German contribution rate rise "would not destroy economy"
This article was originally published in Clinica
German health service costs will continue to rise because medical progress cannot be halted, says Professor Jorg-Dietrich Hoppe, president of the federal doctors' chamber. Speaking at Medica 2001 last week in Dusseldorf, he added that the increasing ability to treat more elderly patients would also add to the financial burden of the healthcare sector.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.